Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure

Robert H. Bartlett, Mark T. Ogino, Daniel Brodie, David M. McMullan, Roberto Lorusso, Graeme Maclaren, Christine M. Stead, Peter Rycus, John F. Fraser, Jan Belohlavek, Leonardo Salazar, Yatin Mehta, Lakshmi Raman, Matthew L. Paden

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Disclaimer: ECMO has, and will certainly continue, to play a role in the management of COVID-19 patients. It should be emphasized that this initial guidance is based on the current best evidence for ECMO use during this pandemic. Guidance documents addressing additional portions of ECMO care are currently being assembled for rapid publication and distribution to ECMO centers worldwide.

Original languageEnglish (US)
Pages (from-to)472-474
Number of pages3
JournalASAIO Journal
DOIs
StateAccepted/In press - 2020

Keywords

  • COVID-19
  • acute respiratory distress syndrome
  • extracorporeal membrane oxygenation
  • pandemic

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering

Fingerprint Dive into the research topics of 'Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure'. Together they form a unique fingerprint.

  • Cite this

    Bartlett, R. H., Ogino, M. T., Brodie, D., McMullan, D. M., Lorusso, R., Maclaren, G., Stead, C. M., Rycus, P., Fraser, J. F., Belohlavek, J., Salazar, L., Mehta, Y., Raman, L., & Paden, M. L. (Accepted/In press). Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure. ASAIO Journal, 472-474. https://doi.org/10.1097/MAT.0000000000001173